1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. EL.En. S.p.A.
  6. News
  7. MarketScreener Strategies
    ELN   IT0005453250

EL.EN. S.P.A.

(ELN)
  Report
Delayed Borsa Italiana  -  05/27 11:35:56 am EDT
12.43 EUR   +0.97%
05/25EL EN S P A : Notice of the publication and availability of the minutes of the Shareholders' meeting occurred on April 29th, 2022 and the relevant updated by-laws
PU
05/23EL.EN. S.P.A. : Ex-dividend day for final dividend
FA
05/16TRANSCRIPT : EL.En. S.p.A., Q1 2022 Earnings Call, May 16, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

EL.En. S.p.A. : The underlying trend is to the upside

12/17/2021 | 03:10am EDT
long trade
Stop-loss triggered
Entry price : 14.66€ | Target : 17.6€ | Stop-loss : 12.6€ | Potential : 20.05%
The underlying tendency is to the upside for shares in EL.En. S.p.A. and the timing is opportune to get back into the stock. A comeback of the upward dynamic can be anticipated.
Investors have an opportunity to buy the stock and target the € 17.6.
EL.En. S.p.A. : EL.En. S.p.A. : The underlying trend is to the upside
Summary
  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.

© MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2022 659 M 706 M 706 M
Net income 2022 55,0 M 58,9 M 58,9 M
Net cash 2022 130 M 140 M 140 M
P/E ratio 2022 18,0x
Yield 2022 1,81%
Capitalization 992 M 1 063 M 1 063 M
EV / Sales 2022 1,31x
EV / Sales 2023 1,14x
Nbr of Employees -
Free-Float 51,8%
Upcoming event on EL.EN. S.P.A.
05/31/22Roadshow
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 12,43 €
Average target price 18,05 €
Spread / Average Target 45,2%
EPS Revisions
Managers and Directors
Andrea Cangioli Co-Chief Executive Officer & Executive Director
Gabriele Clementi Chairman & Co-Chief Executive Officer
Barbara Bazzocchi Co-Chief Executive Officer & Executive Director
Michele Legnaioli Independent Non-Executive Director
Fabia Romagnoli Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
EL.EN. S.P.A.-20.22%1 063
THERMO FISHER SCIENTIFIC-19.05%224 053
DANAHER CORPORATION-19.00%190 779
INTUITIVE SURGICAL, INC.-36.22%82 258
SIEMENS HEALTHINEERS AG-14.49%67 624
EDWARDS LIFESCIENCES CORPORATION-21.95%62 872